Supernus Pharmaceuticals
SUPN
#4182
Rank
ยฃ1.96 B
Marketcap
ยฃ34.29
Share price
1.29%
Change (1 day)
18.28%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of September 2025 : ยฃ1.06 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are ยฃ1.06 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ1.09 B8.7%
2023-12-31ยฃ1.00 B-28.74%
2022-12-31ยฃ1.40 B12.46%
2021-12-31ยฃ1.25 B13.4%
2020-12-31ยฃ1.10 B24.71%
2019-12-31ยฃ0.88 B14.87%
2018-12-31ยฃ0.77 B145.27%
2017-12-31ยฃ0.31 B25.18%
2016-12-31ยฃ0.25 B97.1%
2015-12-31ยฃ0.12 B44.88%
2014-12-31ยฃ87.85 M30.56%
2013-12-31ยฃ67.28 M15.72%
2012-12-31ยฃ58.15 M68.22%
2011-12-31ยฃ34.56 M13.52%
2010-12-31ยฃ30.45 M-38.33%
2009-12-31ยฃ49.37 M-6.18%
2008-12-31ยฃ52.62 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
ยฃ5.51 B 417.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ86.27 B 7,995.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ72.72 B 6,724.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ63.19 B 5,829.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ144.73 B 13,480.98%๐Ÿ‡บ๐Ÿ‡ธ USA